DEDD, a novel death effector domain-containing protein, targeted to the nucleolus

The CD95 signaling pathway comprises proteins that contain one or two death effector domains (DED), such as FADD/Mort1 or caspase‐8. Here we describe a novel 37 kDa protein, DEDD, that contains an N‐terminal DED. DEDD is highly conserved between human and mouse (98.7% identity) and is ubiquitously e...

Full description

Saved in:
Bibliographic Details
Published in:The EMBO journal Vol. 17; no. 20; pp. 5974 - 5986
Main Authors: Stegh, Alexander H., Schickling, Olaf, Ehret, Andreas, Scaffidi, Carsten, Peterhänsel, Christoph, Hofmann, Thomas G., Grummt, Ingrid, Krammer, Peter H., Peter, Marcus E.
Format: Journal Article
Language:English
Published: Chichester, UK John Wiley & Sons, Ltd 15-10-1998
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The CD95 signaling pathway comprises proteins that contain one or two death effector domains (DED), such as FADD/Mort1 or caspase‐8. Here we describe a novel 37 kDa protein, DEDD, that contains an N‐terminal DED. DEDD is highly conserved between human and mouse (98.7% identity) and is ubiquitously expressed. Overexpression of DEDD in 293T cells induced weak apoptosis, mainly through its DED by which it interacts with FADD and caspase‐8. Endogenous DEDD was found in the cytoplasm and translocated into the nucleus upon stimulation of CD95. Immunocytological studies revealed that overexpressed DEDD directly translocated into the nucleus, where it co‐localizes in the nucleolus with UBF, a basal factor required for RNA polymerase I transcription. Consistent with its nuclear localization, DEDD contains two nuclear localization signals and the C‐terminal part shares sequence homology with histones. Recombinant DEDD binds to both DNA and reconstituted mononucleosomes and inhibits transcription in a reconstituted in vitro system. The results suggest that DEDD is a final target of a chain of events by which the CD95‐induced apoptotic signal is transferred into the nucleolus to shut off cellular biosynthetic activities.
Bibliography:ark:/67375/WNG-4F2V11TJ-4
istex:540D25073C5B8BF66207C2E999FF54A3D2AAF2DA
ArticleID:EMBJ7591290
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0261-4189
1460-2075
1460-2075
DOI:10.1093/emboj/17.20.5974